Fact CheckerSign in

NCT07827729Completed

Aromatherapy and Music on Sleep and Children With Epilepsy

The Effects of Aromatherapy and Music Listening on Sleep and Cerebral Oxygen Levels in Children With Epilepsy

Source: ClinicalTrials.gov · Last updated 18 Sept 2026

Brief summary (registry, in English)

Purpose: This study aimed to compare the effects of aromatherapy and music listening with routine care on sleep parameters and cerebral oxygenation in children with epilepsy. Design and methods: This randomized controlled experimental study was conducted between February and December 2023 with children diagnosed with epilepsy living in Malatya Province and surrounding regions. The sample consisted of 90 children allocated to aromatherapy (n = 30), music listening (n = 30), and control (n = 30) groups. Children in the intervention groups received aromatherapy or music listening, whereas the control group received routine care only. Data were collected using the Patient Introduction and Follow-up Form, actigraphy, and the Cerebral Oxygen Monitoring Form. One-way ANOVA, Kruskal-Wallis, chi-square, Mann-Whitney U, LSD, and Dunnett's C tests were used for data analysis. Results: Aromatherapy was associated with higher cerebral oxygen levels, longer time spent in bed, longer sleep duration, higher sleep efficiency, and lower sleep onset latency (p \< 0.05). Similarly, music listening was associated with higher cerebral oxygen levels, longer sleep duration, and higher sleep efficiency (p \< 0.05). Conclusion: Aromatherapy and music listening may improve selected sleep parameters and cerebral oxygenation in children with epilepsy. Practice implications: Aromatherapy and music listening may be considered supportive, non-pharmacological interventions for improving sleep and cerebral oxygenation in pediatric epilepsy care.

Status (registry)
Completed
Study type
Interventional
Enrollment
90 (actual)
First submitted
11 Sept 2026
Start date
1 Feb 2023
Primary completion date
15 Aug 2023
Lead sponsor
Kafkas University
Diseases
Epilepsy
NCT number
NCT07827729

What you commit to

  • Study type: Interventional
  • Participants enrolled: 90
  • From 1 Feb 2023 to the primary completion date, 15 Aug 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Children with resistant epilepsy,
  • Children diagnosed with sleep disorders,
  • Children diagnosed with neurological, psychiatric, or medical disorders other than epilepsy,
  • Children with allergies,

Other

  • Children with hearing problems,
  • Children with impaired sense of smell,
  • Children whose parents did not give consent were excluded from the study.

Who the study is looking for

  • Generalized tonic-clonic seizure,
  • Children who take at least one antiepileptic drug.

Age in the registry: 3 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Inonu University Turgut Ozal Medical Center
Coordinator of this site? Confirm its status
MalatyaTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.